GlassScriptPhysician profile
Sanjeev Nayyar
NPI 1033193628
$1,029.99
in general payments reported to CMS, 2019-2025
17 companies · $22.26 in 2025
The $22.26 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.40 · 2020: $315 · 2021: $167 · 2022: $156 · 2023: $274 · 2024: $53.78 · 2025: $22.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $280.77 | 2020-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $274.66 | 2019-2022 | |
| Evoke Pharma, INC. | $91.90 | 2021-2023 | Gimoti |
| Boston Scientific Corporation | $82.55 | 2020 | |
| Pfizer INC. | $44.99 | 2019-2024 | |
| Genzyme Corporation | $39.25 | 2023-2024 | |
| Laborie Medical Technologies Corp. | $35.61 | 2023 | |
| Abbott Laboratories | $35.43 | 2023 | Freestyle Libre 3 |
| Celltrion USA INC. | $29.32 | 2024-2025 | Vegzelma |
| Pentax of America, INC. | $23.13 | 2022 | |
| Abiomed | $17.07 | 2023 | Impella |
| Qol Medical, LLC | $15.00 | 2022 | |
| Celgene Corporation | $14.41 | 2023 | Zeposia |
| Redhill Biopharma INC. | $14.03 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.71 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.69 | 2022 | |
| Phathom Pharmaceuticals, INC. | $8.47 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Nayyar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.